Anti-Human Vascular Endothelial Growth Factor
Anti-Human Vascular Endothelial Growth Factor
Product No.: V111
- -
- -
Target Vascular Endothelial Growth Factor Product Type Monoclonal Antibody Alternate Names VEGFA, MGC70609, VPF, VAS, Folliculostellate Cell-Derived Growth Factor, Glioma-Derived Endothelial Cell Mitogen Isotype IgG2a Applications ELISA Cap , WB |
- -
- -
Antibody DetailsProduct DetailsReactive Species Human Host Species Mouse Immunogen Purified Recombinant Human VEGF (>98%) Formulation This purified monoclonal antibody is aseptically filtered and lyophilized from PBS with no carrier proteins or preservatives added. Storage and Handling This lyophilized monoclonal antibody should be stored desiccated at -20°C. For long-term storage of the reconstituted antibody, aseptically aliquot into working volumes and store at -20°C in a manual defrost freezer. Avoid Repeated Freeze Thaw Cycles. Country of Origin USA Shipping Next Day Ambient RRIDAB_2832134 Each investigator should determine their own optimal working dilution for specific applications. See directions on lot specific datasheets, as information may periodically change. DescriptionSpecificity Anti-Human Vascular Endothelial Growth Factor (VEGF) recognizes Human Vascular Endothelial Cell Growth Factor. This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype. Background Vascular endothelial growth factor (VEGF), a potent proangiogenic cytokine1 is the key signal used by oxygen-hungry cells to promote growth of blood vessels. It binds to specialized receptors on the surfaces of endothelial cells and directs them to build new vessels.2 VEGF are crucial regulators of vascular development during embryogenesis (vasculogenesis) and blood-vessel formation in the adult (angiogenesis). Abnormal VEGF function is associated with inflammatory diseases including atherosclerosis, and hyperthyroidism.3,4,5,6 Antigen DetailsReferences & Citations1. Folkman J et al. (2008) FASEB J. 22: 3728
2. Goodsell DS et al. (2002) The Oncologist 7: 569
3. Mugishima H. et al. (2006) J Atheroscler Thromb. 13: 130
4. Claesson-Welsh L et al. (2006) Exp Cell Res. 312: 549
5. Claesson-Welsh L et al. (1999) Trends Biochem Sci. 28: 488
6. Ellis LM et al. (2005) J Clin Oncol. 23: 1011 Technical Protocols |
Related Products
- -
- -
Prod No. | Description |
---|---|
V111 | |
V107 | |
V167 |
Products are for research use only. Not for use in diagnostic or therapeutic procedures.